These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869 [TBL] [Abstract][Full Text] [Related]
9. Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis. Johannes H; Malte W; Shaima A; Marcial S; Sören W; Anastasiya P; Christina WN; Christoph S; Willhelm LA; Till K; Jörg S Liver Int; 2023 Jun; 43(6):1269-1276. PubMed ID: 37066519 [TBL] [Abstract][Full Text] [Related]
10. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids. Sharma S; Agarwal S; Gopi S; Anand A; Mohta S; Gunjan D; Yadav R; Saraya A J Clin Exp Hepatol; 2021; 11(2):171-180. PubMed ID: 33746441 [TBL] [Abstract][Full Text] [Related]
11. Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels. Chen Y; Liu J; Wang J; Wu W; Wang H; Liu Y; Zhang Z; Zhang S; Pan Y; Li Y; Ding W; Zhu L; Zhu C; Li J; Qiu Y; Huang R; Wu C J Transl Autoimmun; 2024 Jun; 8():100220. PubMed ID: 38188039 [TBL] [Abstract][Full Text] [Related]
14. Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease. Zachou K; Azariadis K; Lytvyak E; Snijders RJALM; Takahashi A; Gatselis NK; Robles M; Andrade RJ; Schramm C; Lohse AW; Tanaka A; Drenth JPH; Montano-Loza AJ; Dalekos GN; JHEP Rep; 2023 Aug; 5(8):100778. PubMed ID: 37456672 [TBL] [Abstract][Full Text] [Related]
15. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome]. Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851 [TBL] [Abstract][Full Text] [Related]
16. B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis. Biewenga M; Heidt S; Vergunst M; Marijnissen CMJ; de Man RA; van der Eijk AA; van der Meer AJ; Trouw LA; van Hoek B JHEP Rep; 2022 May; 4(5):100460. PubMed ID: 35368991 [TBL] [Abstract][Full Text] [Related]
17. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis. Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715 [TBL] [Abstract][Full Text] [Related]
18. Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature. Taneja S; Kumar P; Mitra S; Duseja A; Minz R; Das A; Dhiman RK; Chawla Y J Clin Exp Hepatol; 2018 Mar; 8(1):98-103. PubMed ID: 29743801 [TBL] [Abstract][Full Text] [Related]
19. Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review. Li Y; Yan L; Wang R; Wang Q; You Z; Li B; Zhang J; Huang B; Chen Y; Li Y; Lian M; Tang R; Qiu D; Gershwin ME; Xiao X; Miao Q; Ma X Clin Rev Allergy Immunol; 2022 Apr; 62(2):292-300. PubMed ID: 33512642 [TBL] [Abstract][Full Text] [Related]
20. Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis. Arvaniti P; Giannoulis G; Gabeta S; Zachou K; Koukoulis GK; Dalekos GN JHEP Rep; 2020 Aug; 2(4):100123. PubMed ID: 32671332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]